You are here

PRACTICAL ASPECTS OF 68GA-LABELLED DOTAPEPTİDES FOR PEPTİDE-RECEPTOR RADİONUCLİDE THERAPY

Journal Name:

Publication Year:

Author NameUniversity of AuthorFaculty of Author
Abstract (2. Language): 
68Gallium-labeled receptor ligands, such as 68Gallium DOTATOC, 68Gallium-DOTANOC, and 68Gallium-DOTATATE which are used in PET are becoming gold standard of 68Ga-labeled peptides. The 68Ga-labeled peptides show a rapid renal clearance and are rapidly accumulated in the tumors (80% within 30 minutes); concentration in tissues without expression of somatostatin receptors is low, providing higher contrast imaging. Here, this paper presents the practical aspects and the results of preparation and radiolabelling DOTA-peptides with TiO2-based commercially available 68Ge/68Ga generator by using fully automated radiopharmaceutical synthesis device. The radiochemical purity (RCP) of 68Ga-labeled DOTA-peptides has been investigated using high performance liquid chromatography (HPLC) and instant thin layer chromatography (ITLC). The labeling procedure resulted in high radiochemical yield. The system allows the fully automated, efficient and rapid preparation of 68Ga-DOTA-derivatized peptides.
149
155

REFERENCES

References: 

[1] Hayes RL, Carlton JE, Byrd BL., “Bone scanning with gallium-68 a carrier effect.” J.
Nucl. Med. 6 (1965): 605-610.
[2] Shealy, C.N., Aronow, S., Brownell, GL. “Gallium-68 as a scanning agent for intracranial
lesions.” J. Nucl. Med. 5 (1964): 161-167.
[3] Deutsch, E., “Clinical PET: its time has come?” J. Med. 3 (1993):1132-1133.
[4] Rösch F., Knapp F.F. (Russ), Radionuclide Generators. in A Vértes, S Nagy, Z Klencsár,
F Rösch (eds.), “Handbook of Nuclear Chemistry 4” Kluwer Academic Publishers, The
Netherlands (2003): 81-118.
[5] Hofmann, M., Maecke, H., Börner, A.R., Weckesser, E., Schöffski, P., Oei, M.L.,
Schumacher, J., Henze, M., Heppeler, A., Meyer, G.J. and Knapp, W.H., “Biokinetics
and imaging with the somatostatin receptor PET radioligand 68Ga-DOTATOC:
preliminary data.” Eur. J. Nucl. Med. 28 (2001): 1751–1757.
[6] Wild, D., Schmitt, J.S., Ginj, M., Macke, H.R., Bernard, B.F., Krenning, E., “DOTA NOC,
a high- affinity ligand of somatostation receptor subtypes 2, 3 and 5 for labeling with
various radiometals.” Eur. J. Nucl. Med. Mol. Imag. 30 (2003): 1338-1347.
[7] Gabriel, M., Decristoforo, C., Kendler, D., Dobrozemsky, G., Heute, D., Uprimny, C.,
Kovacs, P., von Guggenberg, E., Bale R., and Virgolini, I.J., “68Ga-DOTA-Tyr3-
Octreotide PET in neuroendocrine tumors: comparison with somatostatin receptor
scintigraphy and CT. J. Nucl. Med.” 48 (2007): 508–518.
[8] Schuhmacher, J. and Maier, B.W., “A new 68Ge/68Ga radioisotope generator system for
production of 68Ga in dilute HCl. ” Int. J. Appl. Radiat. Isot. 32 (1981): 31–36.
[9] Decristoforo, C., Knopp, R., von Guggenberg, E., Rupprich, M., Reger, T., Hess, A.,
Virgolini, I. and Haubner, R., “A fully automated synthesis for the preparation of 68Galabelled
peptides. Nucl. Med. Commun.” 28 (2007): 870–875.
[10] Meyer, G.J.,. Maecke, H.,. Schuhmacher, J, Knapp, W.H and Hofmann, M. “68Galabelled
DOTA-derivatised peptide ligands.” Eur. J. Nucl. Med. Mol. Imaging 31 (2004):
1097–1104.
[11] Nakayama, M., Haratake, M., Ono, M., Koiso, T., Harada, K., Nakayama, H., Yahara,
S., Ohmomo, Y. and Arano, Y., “A new 68Ge/68Ga generator system using an Organic
polymer containing N-methylglucamine groups as adsorbent for 68Ge” Appl. Radiat. Isot.,
58 (2004):9–14.
155
[12] Velikyan, I., Beyer, G.J., and Långström, B., “Microwave-supported preparation of 68Ga
bioconjugates with high specific radioactivity.” Bioconjugate Chem. 15 (2004):554–560.
[13] Zhernosekov, K.P., Filosofov, D.V., Baum, R.P., Aschoff, P., Bihl, H., Razbash, A.A.,
Jahn, M., Jennewein , M.. and Rösch, F., “Processing of generator-produced Ga-68 for
medical application.” J. Nucl. Med. 48 (10) (2007) 1741–1748.
[14] Ocak, M., Antretter, M., Knopp, R., Kunkel, F., Petrik, M., Bergisadi, N., Decristoforo,
C., “Full automation of 68Ga labeling of DOTA-peptides including cation exchange
prepurification.” Appl. Radiat. Isot., 68 (2010): 297-302.
[15] Breeman, W.A.P., de Jong, M., de Blois, E., Bernard, B.F., Konijnenberg M. and
Krenning, E.P., Radiolabelling DOTA-peptides with 68Ga. Eur. J. Nucl. Med. Mol.
Imaging 32 (2005) 478–485.

Thank you for copying data from http://www.arastirmax.com